| 000 | 01163 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513100037.0 | ||
| 264 | 0 | _c19961209 | |
| 008 | 199612s 0 0 eng d | ||
| 022 | _a0883-5896 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoore, M P | |
| 245 | 0 | 0 |
_aIs axillary lymph node dissection necessary in the routine management of breast cancer? Yes. _h[electronic resource] |
| 260 |
_bImportant advances in oncology _c1996 |
||
| 300 |
_a245-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAxilla _xsurgery |
| 650 | 0 | 4 |
_aBreast Neoplasms _xmortality |
| 650 | 0 | 4 |
_aCarcinoma _xdiagnosis |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymph Node Excision _xadverse effects |
| 650 | 0 | 4 |
_aLymphatic Metastasis _xdiagnosis |
| 650 | 0 | 4 |
_aLymphedema _xetiology |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aKinne, D W | |
| 773 | 0 |
_tImportant advances in oncology _gp. 245-50 |
|
| 999 |
_c8787695 _d8787695 |
||